Clinical trial
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic…
NCT00098852 · University of California, San Francisco, Other · Unknown status
Key facts
| NCT number | NCT00098852 |
|---|---|
| Title | Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer |
| Official title | A Pilot Study of Rosiglitazone in Patients With Incurable Differentiated Thyroid Cancer |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | rosiglitazone maleate |
| Enrollment | 25 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2010 |
| First posted | Dec 9, 2004 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: